证券代码：600829 证券简称：人民同泰 公告编号：临 2025-037 哈药集团人民同泰医药股份有限公司（以下简称"公司"）第十 一届董事会第四次会议通知于 2025 年 11 月 21 日以书面及电子邮件 方式向全体董事发出，会议于 2025 年 11 月 28 日以通讯会议方式召 开。本次会议应出席董事 7 人，实际出席董事 7 人。本次会议的召集、 召开和表决程序符合《公司法》《公司章程》《董事会议事规则》的 规定。 二、董事会会议审议情况 经全体董事认真审议，本次会议以记名投票表决方式表决通过了 如下议案： （一）审议通过《关于修订<董事会提案管理制度>的议案》 具体内容详见公司同日在上海证券交易所网站（www.sse.com.cn） 及指定媒体披露的《董事会提案管理制度》。 表决结果：7 票同意，0 票反对，0 票弃权。 全体董事出席本次会议。 本次董事会无反对或弃权票。 本次董事会议案全部获得通过。 哈药集团人民同泰医药股份有限公司 第十一届董事会第四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任 ...

Group 1 - Several companies, including Shuyupingmin, Huaren Health, and Kaikai Industry, experienced a decline of over 6% [1] - Other companies such as Yaoyigou, Renmintongtai, Yingtigroup, Diyi Medical, and Yifeng Pharmacy also followed the downward trend [1]

Market Overview - The market exhibited a fragmented low-volume trading pattern, with the Shanghai Composite Index slightly down by 0.15%, while the Shenzhen Component and ChiNext Index rose by 1.02% and 2.14% respectively. Approximately 3,600 stocks declined against over 1,600 that rose, with total trading volume reaching 1.7 trillion [1][3]. AI Hardware Sector - The AI hardware sector saw significant gains, with OCS continuing to strengthen and the CPO sector experiencing a collective rise. Key stocks such as Special Information and Zhongji Xuchuang hit new highs, while others like Saimicroelectronics and Yuxi Technology also saw substantial increases [4][6][7]. Consumer Sector - The consumer sector experienced a resurgence in the afternoon following the release of a plan by six departments aimed at enhancing the adaptability of consumer goods supply and demand. This plan anticipates the formation of three trillion-level consumption areas and ten billion-level consumption hotspots by 2027. Retail stocks like Dongbai Group and Sanjiang Shopping surged, with several stocks hitting the daily limit [9][10]. Shenzhen Local Stocks - Following the announcement of a financial support plan for enterprises in Guangdong, Shenzhen local stocks initially showed little reaction but later surged in the afternoon, led by stocks like Teli A and Shenhua A. The rally was partly driven by news regarding Vanke's debt situation and restructuring plans, which sparked interest in related local stocks [12][14][15][17]. Reader Culture - Reader Culture experienced a sudden surge of over 7% in the afternoon, closing with a 5.1% increase. The rise was attributed to heightened media attention surrounding figures like Luo Yonghao, suggesting that market movements may be influenced by social media trends rather than fundamental factors [20].

Group 1 - The overall performance of China's A-shares on November 26 was stable, with major indices showing more gains than losses [1] - The pharmaceutical commercial sector led the market with a notable increase of 3.24%, outperforming all other industry sectors [1] - Individual stocks such as Huaren Health, Haiwang Biological, Renmin Tongtai, and Ruikang Pharmaceutical reached their daily price limits, with Huaren Health achieving a 20% increase [1] Group 2 - Analysts from Bohai Securities highlighted the long-term positive outlook for China's innovative drug industry chain, with leading companies gaining international recognition and overall industry prosperity on the rise [1] - The recent surge in flu cases has increased the demand for flu treatment medications, presenting a temporary investment opportunity for related listed companies [1] - Data from e-commerce platforms indicated a significant spike in demand for flu-related medications, with Alibaba Health reporting a notable increase in purchases of anti-flu drugs over the two weeks from November 10 to November 23 [1]

Core Viewpoint - The pet economy sector experienced a slight increase of 0.14% on November 26, with Renmin Tongtai leading the gains, while the overall market showed mixed results with the Shanghai Composite Index down by 0.15% and the Shenzhen Component Index up by 1.02% [1] Group 1: Market Performance - The Shanghai Composite Index closed at 3864.18, down 0.15% [1] - The Shenzhen Component Index closed at 12907.83, up 1.02% [1] - The pet economy sector stocks showed varied performance, with Renmin Tongtai rising by 10.02% to a closing price of 13.18 [1] Group 2: Individual Stock Performance - Renmin Tongtai (600829) led the sector with a closing price of 13.18 and a trading volume of 538,900 shares, resulting in a transaction value of 672 million [1] - Aoni Electronics (301189) increased by 6.34% to 40.09, with a transaction value of 332 million [1] - Xinhua Pharmaceutical (000756) rose by 5.77% to 18.15, with a transaction value of 159.5 million [1] Group 3: Capital Flow - The pet economy sector saw a net outflow of 27.86 million from institutional investors and 74.23 million from retail investors, while retail investors had a net inflow of 102 million [2][3] - Renmin Tongtai experienced a net inflow of 115 million from institutional investors, despite a net outflow of 51.93 million from retail investors [3] - Xinhua Pharmaceutical had a net inflow of 68.19 million from institutional investors, with a net outflow of 21.72 million from retail investors [3]

Market Overview - The pharmaceutical commercial sector increased by 1.34% compared to the previous trading day, with Huaren Health leading the gains [1] - The Shanghai Composite Index closed at 3864.18, down 0.15%, while the Shenzhen Component Index closed at 12907.83, up 1.02% [1] Stock Performance - Huaren Health (301408) saw a closing price of 17.40, with a significant increase of 20.00% and a trading volume of 345,500 shares, amounting to a transaction value of 570 million [1] - Other notable performers included: - Haiwang Biological (000078) with a closing price of 2.81, up 10.20% [1] - Renmin Tongtai (600829) at 13.18, up 10.02% [1] - Ruikang Pharmaceutical (002589) at 3.19, up 10.00% [1] - Yingte Group (000411) at 12.36, up 9.96% [1] Capital Flow - The pharmaceutical commercial sector experienced a net inflow of 665 million from main funds, while retail funds saw a net outflow of 366 million [2] - The main funds' net inflow for Huaren Health was 1.43 billion, representing 25.12% of the total, while retail funds had a net outflow of 596.87 million [3] - Other companies with significant main fund inflows included: - Ruikang Pharmaceutical with a net inflow of 118 million [3] - Renmin Tongtai with a net inflow of 115 million [3] - Haiwang Biological with a net inflow of 106 million [3]

Group 1 - Four companies have received court approval for restructuring investments [2] - Aowannianqing's product, Zhongzubei Dingchuan Wan, focuses on treating respiratory issues [2] - Beida Pharmaceutical has expanded its business scope to include both chemical synthesis and biopharmaceuticals [2] - Zhongheng Group's subsidiary acquired a technology for treating chronic heart failure for 55 million yuan [2] - Huaren Health is focused on the pharmaceutical distribution industry, with Alibaba Health as a significant shareholder [2] - Haiwang Biological is one of the largest national pharmaceutical commercial enterprises in China [2] - Fuyuan Pharmaceutical's Lansoprazole enteric-coated capsules have been approved for registration [2] - People's Tongtai is the largest pharmaceutical commercial company in Heilongjiang Province [2] - Yinghe Group is a regional leader in pharmaceutical distribution in Zhejiang Province [2] - Ruikang Pharmaceutical has completed special item approval for the import of Evusheld, a COVID-19 prevention drug [2] - Jindike is one of the first companies to achieve the approval and sale of quadrivalent influenza vaccines [2] Group 2 - Dairong has completed the transfer of shares with Zhongdao Chenying [3] - Boyong Generation is a leader in the domestic ETC chip field [3] - Wantong Development plans to invest 854 million yuan to acquire a 62.98% stake in Shudu Technology [3] - Mingwei Electronics collaborates with major manufacturers for chip production [3] - Qipilong is a leading Chinese men's clothing brand [3] - Dongxin Co. is one of the few companies in mainland China providing complete solutions for NAND, NOR, and DRAM chips [3] - The National Space Administration has issued a plan to promote the high-quality development of commercial aerospace [3] - Sanwei Tiandi has clients including China Aerospace for its digital inspection and testing management services [3] - Leike Defense has developed a comprehensive satellite application business [3] - Tianqimo has sufficient orders for its aviation parts business [3] Group 3 - The implementation plan to enhance the adaptability of supply and demand for consumer goods has been issued [4] - Maoye Commercial is a retail market leader in Hohhot [4] - Jialinjie is a leader in functional fabrics for outdoor sports [4] - Xueqi Electric specializes in the production of refrigerators and commercial display cabinets [4] - Guangbai Co. is the largest department store chain in Guangzhou [4] - Mengjie Co. has launched the first children's home textile brand in the industry [4] - Juran Smart Home has signed a strategic cooperation agreement following the chairman's passing [4] - Haixin Food is a leading company in the frozen fish ball market [4] - Sanjiang Shopping is the largest local supermarket chain in Zhejiang Province [4] - Jiangxi Province's first listed company in the commercial circulation industry is Guoguang Chain [4] Group 4 - The company is a leading e-commerce platform for liquor, with various brand partnerships [5] - Shiji Group plans to acquire a 95% stake in Fujian Shuchuan Ming Shang for 184.6 million yuan [5] - Laizhi Group specializes in new materials for construction additives [5] - Dahua Intelligent has developed a complete quantum secure satellite internet communication solution [5] - Haitong Development operates dry bulk shipping services across over 200 ports [5] - Qingshan Paper is a major supplier of optical communication modules and components [5] Group 5 - Ningbo Color Masterbatch has launched a high-transparency POE film crosslinking masterbatch [6] - BOLE FREE STARS' app surpassed 10 million downloads in its first week [6] - Hainan Free Trade Port is set to launch on December 18 [6] - Hainan Ruize focuses on concrete and new wall materials production [6] - Tianpu Co. has completed the transfer of shares with Zhonghuang Chenying [6] - Longsao Technology has increased its sales contract for lithium iron phosphate materials significantly [6] Group 6 - The company has developed energy storage products covering various systems and collaborated with international wind power leaders [7] - Huanyue Century has established an AI joint laboratory for content production [7] - Luoping Zinc Electric is the only enterprise in the zinc smelting industry with a tri-production model [7] - Meiyan Jixiang operates seven hydropower stations in Guangdong [7] - Qingshang Co. has developed smart city products using streetlights as a platform [7] - Meike Home focuses on domestic retail and international wholesale of home products [7] Group 7 - Chitianhua is the largest methanol producer in Guizhou, with an annual capacity of 300,000 tons [8] - Weiyuan Co. is the largest producer of phenol and acetone in China [8] - Teli A is controlled by the Shenzhen State-owned Assets Supervision and Administration Commission [8] - Hongmian Co. is a state-owned enterprise in Guangzhou focusing on daily chemical products [8] - Zhonghuan Hailu produces various industrial metal forgings for multiple sectors [8]

Group 1 - The stock price of Renmin Tongtai dropped by 2.00% on November 26, trading at 11.74 CNY per share, with a total market capitalization of 6.808 billion CNY [1] - Year-to-date, Renmin Tongtai's stock price has increased by 56.53%, but it has seen a decline of 26.39% over the last five trading days [1] - The company has appeared on the "Dragon and Tiger List" 13 times this year, with the most recent appearance on November 21, where it recorded a net buy of -7.5568 million CNY [1] Group 2 - Renmin Tongtai Pharmaceutical Co., Ltd. was established on February 19, 1994, and is primarily engaged in pharmaceutical wholesale, retail, and medical services [2] - The company's revenue composition includes 57.72% from wholesale to medical clients, 22.26% from wholesale to commercial clients, and 18.91% from retail [2] - As of September 30, the number of shareholders increased to 27,700, with an average of 20,900 circulating shares per shareholder [2] Group 3 - Renmin Tongtai has distributed a total of 1.671 billion CNY in dividends since its A-share listing, with 83.504 million CNY distributed in the last three years [3]

Investment Rating - The report does not explicitly state an investment rating for the industry or companies involved [5][6]. Core Insights - The 13th Committee's 8th Plenary Session successfully passed the "14th Five-Year Plan" development proposal, emphasizing the transformation direction of "five changes and one advancement" to convert various advantages into development momentum [5][11]. - The focus during the "14th Five-Year" period will be on four major directions to accelerate the construction of a new highland for opening up to the north, including deepening cooperation with Russia and expanding into diverse markets [12]. - The Black龙江板块 index experienced a significant adjustment, dropping 2.63% in November, with a notable decline of 7.31% from November 17 to 21, indicating a bearish market sentiment [21][24]. Summary by Sections Economic Development - The "14th Five-Year" plan outlines 15 parts and 62 articles, detailing development tasks across three major sectors, aiming for a modernized strong province [5][11]. - The province aims to enhance its international economic cooperation and optimize the foreign investment environment, promoting the "Investment Longjiang" brand [12]. Market Performance - The Black龙江板块 index has shown a downward trend, with only five companies achieving positive returns during the period from November 10 to 21, with People's Tongtai leading at a 37.59% increase [21][25]. - The overall performance of the listed companies was weak, with 23 companies experiencing declines of over 5%, and 8 companies seeing declines exceeding 10% [21][25]. Industry Insights - The report highlights the importance of collaboration with companies like UBTECH to enhance talent cultivation and industrial upgrading in the province, focusing on the application of humanoid robots in education [15]. - The province's economic data for the first three quarters of the year indicates a stable growth trend, supported by strong import and export performance [21].

New Stock Issuance - The new stock issuance for Moer Thread (证券代码: 787795) is priced at 114.28 RMB per share, effective from November 24, 2025[1] - Tianpu Co., Ltd. (证券代码: 605255) is undergoing a tender offer period from November 20 to December 19, 2025[1] Cash Options - Hangzhou Qilun B (证券代码: 200771) has a cash option declaration period from November 19 to November 25, 2025[1] Market Alerts - Jiumuwang (证券代码: 601566) has reported severe abnormal fluctuations[1] - Hefu China (证券代码: 603122) is also noted for significant abnormal fluctuations[1] Recent Announcements - Huasheng Lithium Battery (证券代码: 688353) and Pinming Technology (证券代码: 688109) have recent announcements regarding their stock activities[1] - ST Yuan Cheng (证券代码: 603388) and ST Keli Da (证券代码: 603828) have also made recent disclosures[1] Trading Updates - The trading updates include various companies with links to their respective announcements, indicating ongoing market activities and potential investment opportunities[1]